Skip to Content

During the funding lapse, is not being supported. If data feeds are not available from GPO, will not be updated, so please use the official edition of the Federal Register on Govinfo ( If there is a technical issue with the Public Inspection List, you can view the documents on public inspection at our office in Washington, DC or on


Government-Owned Inventions; Availability for Licensing; Correction

Document Details

Information about this document as published in the Federal Register.

Document Statistics
Document page views are updated periodically throughout the day and are cumulative counts for this document including its time on Public Inspection. Counts are subject to sampling, reprocessing and revision (up or down) throughout the day.
Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble


National Institutes of Health, HHS.

Start Printed Page 52844


Notice; correction.


The Department of Health and Human Services, National Institutes of Health published a Notice in the Federal Register on October 9, 2018. That Notice inadvertently contained an error within the SUPPLEMENTARY INFORMATION.

Start Further Info


Peter Soukas, J.D., 301-594-8730; Licensing information and copies of the patent applications listed below may be obtained by communicating with the indicated licensing contact at the Technology Transfer and Intellectual Property Office, National Institute of Allergy and Infectious Diseases, 5601 Fishers Lane, Rockville, MD, 20852; tel. 301-496-2644. A signed Confidential Disclosure Agreement will be required to receive copies of unpublished patent applications.

End Further Info End Preamble Start Supplemental Information



In the Federal Register of October 9, 2018, in FR Doc. 2018-21764, on page 50667, in the first column, correct “HHS Reference No. E-018-2018/0” to read “HHS Reference No. E-167-2018-0”.

Start Signature

Dated: October 12, 2018.

Suzanne M. Frisbie,

Deputy Director, Technology Transfer and Intellectual Property Office, National Institute of Allergy and Infectious Diseases.

End Signature End Supplemental Information

[FR Doc. 2018-22722 Filed 10-17-18; 8:45 am]